Most cited papers from Vaccinex (United States)

Vaccinex (United States)

What are the most cited papers from Vaccinex (United States)?

The most cited paper from Vaccinex (United States) is "Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene" (Yasuhiko Nishio, Yufeng Dong, Mark J. Paris et al., 2006), with 346 citations. Next come "A biological classification of Huntington's disease: the Integrated Staging System" (336) and "CXCL13 antibody for the treatment of autoimmune disorders" (127).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 89 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene Yasuhiko Nishio, Yufeng Dong, Mark J. Paris et al. · Gene	30 Mar 2006	346
2	A biological classification of Huntington's disease: the Integrated Staging System Sarah J. Tabrizi, Scott Schobel, Emily C. Gantman et al. · The Lancet Neurology	15 Jun 2022	336
3	CXCL13 antibody for the treatment of autoimmune disorders Ekaterina Klimatcheva, Tracy Pandina, Christine A. Reilly et al. · BMC Immunology Open access	10 Feb 2015	127
4	SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease Ernest Smith et al. · Neurobiology of Disease Open access	18 Oct 2014	121
5	CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis Jill M. Kramer, Ekaterina Klimatcheva, Thomas L. Rothstein · Journal of Leukocyte Biology Open access	Aug 2013	120
6	A High-Affinity Fully Human Anti–IL-6 mAb, 1339, for the Treatment of Multiple Myeloma Mariateresa Fulciniti, Teru Hideshima, Claudine Vermot‐Desroches et al. · Clinical Cancer Research Open access	25 Nov 2009	118
7	Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease Amber L. Southwell, Sonia Franciosi, Erika B. Villanueva et al. · Neurobiology of Disease Open access	3 Feb 2015	109
8	Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies Elizabeth E. Evans, Alan S. Jonason, Holm Bußler et al. · Cancer Immunology Research	23 Jan 2015	108
9	Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection Guanfang Shi, David James Field, Kyung-ae Ko et al. · Journal of Clinical Investigation Open access	26 Jan 2014	99
10	Cross-protective immunity following coronavirus vaccination and coronavirus infection Tanushree Dangi, Nicole Palacio, Sarah Sanchez et al. · Journal of Clinical Investigation Open access	8 Oct 2021	92
11	Immunotherapy in Triple-Negative Breast Cancer Leisha A. Emens · The Cancer Journal	2021	86
12	Antibody against Surface-Bound C5a Peptidase Is Opsonic and Initiates Macrophage Killing of Group B Streptococci Qi Cheng, Brian L. Carlson, Sub Pillai et al. · Infection and Immunity Open access	Apr 2001	75
13	A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk Elad Katz, Sylvie Dubois-Marshall, Andrew H. Sims et al. · British Journal of Cancer Open access	Jul 2010	75
14	Sustained activation and tumor targeting of NKT cells using a CD1d–anti-HER2–scFv fusion protein induce antitumor effects in mice Kathrin Stirnemann, Jackeline F. Romero, Lucia Baldi et al. · Journal of Clinical Investigation Open access	Feb 2008	68
15	Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial Andrew Feigin et al. · Nature Medicine Open access	8 Aug 2022	66
16	Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors Amita Patnaik, Glen J. Weiss, John E. Leonard et al. · Clinical Cancer Research	7 Oct 2015	65
17	Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function Paúl E. Clavijo, Jay Friedman, Yvette L. Robbins et al. · Cancer Immunology Research Open access	4 Dec 2018	62
18	Transforming Growth Factor-β and Wnt Signals Regulate Chondrocyte Differentiation through Twist1 in a Stage-Specific Manner Yu‐Feng Dong, Do Yu Soung, Yoon Soo Chang et al. · Molecular Endocrinology Open access	8 Aug 2007	60
19	C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer Elizabeth E. Evans, Alicia D. Henn, Alan S. Jonason et al. · Molecular Cancer Therapeutics	Nov 2006	56
20	Generation and preclinical characterization of an antibody specific for SEMA4D Terrence Lee Fisher, Christine A. Reilly, Laurie A. Winter et al. · mAbs Open access	2 Oct 2015	55
21	Clinal patterns of desiccation and starvation resistance in ancestral and invading populations of Drosophila subobscura George W. Gilchrist, Lisa M. Jeffers, Brianna West et al. · Evolutionary Applications Open access	31 Jul 2008	54
22	Biology and significance of T‐cell apoptosis in the liver Sun Park, Debbie Murray, Beena John et al. · Immunology and Cell Biology	Feb 2002	49
23	Physician Perspectives Regarding Pneumococcal Conjugate Vaccine Stanley J. Schaffer, Peter G. Szilagyi, Laura Pollard Shone et al. · PEDIATRICS	Dec 2002	48
24	Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection Koji Yamamoto, Shin Nishiumi, Lin Yang et al. · Mucosal Immunology Open access	19 Mar 2014	48
25	LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade Amber Hickman et al. · Journal of Clinical Investigation Open access	12 May 2022	44
26	Development of a Global Respiratory Severity Score (GRSS) for Respiratory Syncytial Virus Infection in Infants Mary T. Caserta, Xing Qiu, Brenda L. Tesini et al. · The Journal of Infectious Diseases Open access	16 Dec 2016	44
27	Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity Elizabeth E. Evans, Vikas A. Mishra, Crystal L. Mallow et al. · Journal of Neuroinflammation Open access	6 Aug 2022	42
28	Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody John E. Leonard, Terrence Lee Fisher, Laurie A. Winter et al. · Molecular Cancer Therapeutics Open access	6 Feb 2015	36
29	Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction Arjun Sharma, Jeremy Kiripolsky, Ekaterina Klimatcheva et al. · Clinical Immunology Open access	28 Jan 2016	35
30	CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses Stéphanie Corgnac, Rachel Perret, Laurent Derré et al. · Cancer Immunology Immunotherapy Open access	14 Dec 2012	35
31	A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non–Small Cell Lung Cancer Michael Rahman Shafique et al. · Clinical Cancer Research	5 Apr 2021	32
32	Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae Muneki Hotomi, Noboru Yamanaka, Jun Shimada et al. · International Journal of Pediatric Otorhinolaryngology	26 Aug 2002	26
33	Saturation monitoring of VX 15/2503, a novel semaphorin 4 D ‐specific antibody, in clinical trials Terrence Lee Fisher, Jennifer Seils, Christine A. Reilly et al. · Cytometry Part B Clinical Cytometry Open access	13 Nov 2015	25
34	Polarization of Porphyromonas gingivalis–specific helper T‐cell subsets by prior immunization with Fusobacterium nucleatum Jeom‐Il Choi, Melinda A. Borrello, Smith Eh et al. · Oral Microbiology and Immunology	Jun 2000	25
35	The Relationship of CD5 + B Lymphocytes to Macrophages: Insights from Normal Biphenotypic B/Macrophage Cells Melinda A. Borrello, James Palis, Richard R. Phipps · International Reviews of Immunology	2001	23
36	Antibody Library Display on a Mammalian Virus Vector: Combining the Advantages of Both Phage and Yeast Display into One Technology Ernest Smith, Maurice Zauderer · Current Drug Discovery Technologies	27 Jan 2014	20
37	Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens Ernest Smith, Aparna Mandokhot, Elizabeth E. Evans et al. · Nature Medicine	Aug 2001	20
38	Construction of cDNA Libraries in Vaccinia Virus Ernest Smith, Shuying Shi, Maurice Zauderer · Humana Press eBooks Book chapter	2004	18
39	Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D Elizabeth E. Evans, Mark J. Paris, Ernest Smith et al. · OncoImmunology Open access	29 May 2015	18
40	31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Casey R. Ager et al. · Journal for ImmunoTherapy of Cancer Open access1,802 authors	Nov 2016	17
41	Enhancing the antitumor functions of invariant natural killer T cells using a soluble CD1d-CD19 fusion protein Rupali Das, Peng Guan, Susan J. Wiener et al. · Blood Advances Open access	11 Mar 2019	16
42	Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation Natacha Veerapen, Shalu Sharma Kharkwal, P. J. Jervis et al. · Bioconjugate Chemistry Open access	7 Aug 2018	16
43	New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016 Prasad S. Adusumilli et al. · Journal for ImmunoTherapy of Cancer Open access	13 Jun 2017	16
44	Anti-Semaphorin 4D Rescues Motor, Cognitive, and Respiratory Phenotypes in a Rett Syndrome Mouse Model Yilin Mao, Elizabeth E. Evans, Vikas A. Mishra et al. · International Journal of Molecular Sciences Open access	31 Aug 2021	15
45	Absolute quantitation of binding antibodies from clinical samples Chan Tang, Annemiek Verwilligen, JERALD C. SADOFF et al. · npj Vaccines Open access	6 Jan 2024	14
46	Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy Shalu Sharma Kharkwal, Christopher T. Johndrow, Natacha Veerapen et al. · Cancer Research Open access	22 Jan 2021	14
47	The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50‐ to 74‐year‐old adults Richard B. Kennedy, Whitney L. Simon, Michael J. Gibson et al. · Immunology Open access	17 May 2016	14
48	Polymorphism of the major surface epitope of the CopB outer membrane protein ofMoraxella catarrhalis Dai-Fang Liu, Xiaoling Xie, Maria G. Mastri et al. · FEMS Immunology & Medical Microbiology Open access	16 May 2006	13
49	Characterization of immunoglobulin E responses in Balb/c mice against the major allergens of timothy grass (Phleum pratense) pollen Ulrike Seitzer, Holm Bußler, Birgit Kullmann et al. · Clinical & Experimental Allergy	May 2003	11
50	Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer Elijah Kirschstein, Olivia E. Harder, Jordan Edward Krull et al. · Cancer Cell	26 Mar 2026	10

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.